Loncar China BioPharma ETF (CHNA) es una empresa que cotiza en bolsa en el Servicios Financieros sector, operando dentro de la Asset Management industria.
CHNA tiene fecha de IPO 2018-08-15, cotiza en el NASDAQ Global Market.
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
